Association of MTHFR Polymorphisms with H-Type Hypertension: A Systemic Review and Network Meta-Analysis of Diagnostic Test Accuracy
Open Access
- 22 March 2022
- journal article
- review article
- Published by Wiley in International Journal of Hypertension
- Vol. 2022, 1-7
Abstract
Purpose. An association between MTHFR polymorphisms and H-type hypertension (H-HTN) has been investigated by epidemiological studies, but results have been inconsistent. Thus, a systematic assessment of the association was performed based on a literature review and pooled analysis, to provide stronger evidence on the effects of single nucleotide polymorphisms on H-HTN risk. Methods. Three investigators independently retrieved relevant studies in PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Wanfang Database, and China Biomedical Literature Database (CBM). A fixed or random effects model was selected to calculate pooled odds ratio (OR) and 95 confidence intervals (CIs). A network meta-analysis of diagnostic test and Thakkinstians algorithm were used to select the most appropriate genetic model, along with false-positive report probability (FPRP) for noteworthy associations. All data were processed using Stata 15.0 and Meta-Disc. Results. A total of 14 studies involving 1759 cases and 1581 controls for MTHFR were included in our meta-analysis. In a direct meta-analysis, we found that MTHFR C667T rs1801133 significantly increased the risk of H-HTN susceptibility except for an overdominant model. However, MTHFR A1298C rs1801131 polymorphism had no significant correlation with H-HTN risk. Besides, MTHFR C667T rs1801133 is a potential diagnostic biomarker for estimating H-HTN risk. The results indicated that the dominant model was an optimal diagnosis model for excluding diseases, which could reduce a missed diagnosis rate and further improve the accuracy of disease diagnosis. Conclusion. The present result suggests that MTHFR C667T rs1801133 polymorphism is associated with H-HTN risk and may act as a promising predictive biomarker for H-HTN risk. However, further well-designed studies are warranted to confirm these results.Keywords
Funding Information
- Guangxi University of Chinese Medicine (2021005, 82160875)
- National Natural Science Foundation of China (2021005, 82160875)
This publication has 29 references indexed in Scilit:
- Association of the C677T Polymorphism in the MTHFR Gene with Hemorrhagic Stroke: A Meta-AnalysisGenetic Testing and Molecular Biomarkers, 2013
- Investigation of Homocysteine‐Pathway‐Related Variants in Essential HypertensionInternational Journal of Hypertension, 2012
- Criteria for Evaluation of Novel Markers of Cardiovascular RiskCirculation, 2009
- STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE StatementPLOS Medicine, 2009
- The pharmacogenetics of methotrexateRheumatology, 2007
- MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based studyEuropean Journal of Neurology, 2004
- A method for meta-analysis of molecular association studiesStatistics in Medicine, 2004
- Evidence for a Gene Influencing Blood Pressure on Chromosome 17Hypertension, 2000
- Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine ConcentrationsCirculation, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995